IVX 50.0% 0.3¢ invion limited

Ann: Pre-clinical research agreement with Peter MacCallum CC, page-12

  1. 307 Posts.
    lightbulb Created with Sketch. 27
    Have to Mike, this is a trading stock not investment, lives and dies on announcements. In this case yet another 'collaboration' while seemingly good simply has done nothing to SP. Real results just all too far off for thinking in terms of investment/cancer treatment. Not trading for the sake of waiting 1-2 years for good results. (Other than 'collaboration')
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.